Drugs / Norovirus -specific T-cell (NST) therapy
Norovirus -specific T-cell (NST) therapy
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04691622 | Mar 2022 → Aug 2028 expected | disease related to hematopoietic stem cell transplant, immunodeficiency disease, viral infectious disease | Children's National Research Institute | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Norovirus -specific T-cell (NST) therapy | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04691622 ↗ |
| Modality | Cell therapy | “norovirus -specific T-cell (NST) therapy” NCT04691622 ↗ |